N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide

C138H149ClF10N24O15 — CID 160824329

IUPACN-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide
SMILESCOc1cc(CC(=O)N(CC(=O)N2CCC(N)CC2)c2nccc(-c3ccccc3)n2)ccc1O.Cc1ccccc1-c1cnccc1N(CC(=O)N1CCCC(N)C1)C(=O)CCc1ccc(O)c(C(F)(F)F)c1.NC1CCCCN(C(=O)CN(C(=O)CCCc2cccc(C(F)(F)F)c2F)c2ccc(OCc3ccccc3)cn2)C1.NC1CCCN(C(=O)CN(C(=O)c2ccc(Cl)c(O)c2)c2ccnc(-c3ccccc3)n2)CC1.NC1CN(C(=O)CN(C(=O)CCCc2cccc(NCC(F)(F)F)c2)c2ccc(-c3ccccc3)nn2)C1
InChIInChI=1S/C31H34F4N4O3.C29H31F3N4O3.C27H29F3N6O2.C26H29N5O4.C25H26ClN5O3/c32-30-23(10-6-13-26(30)31(33,34)35)11-7-14-28(40)39(20-29(41)38-17-5-4-12-24(36)19-38)27-16-15-25(18-37-27)42-21-22-8-2-1-3-9-22;1-19-5-2-3-7-22(19)23-16-34-13-12-25(23)36(18-28(39)35-14-4-6-21(33)17-35)27(38)11-9-20-8-10-26(37)24(15-20)29(30,31)32;28-27(29,30)18-32-22-10-4-6-19(14-22)7-5-11-25(37)36(17-26(38)35-15-21(31)16-35)24-13-12-23(33-34-24)20-8-2-1-3-9-20;1-35-23-15-18(7-8-22(23)32)16-24(33)31(17-25(34)30-13-10-20(27)11-14-30)26-28-12-9-21(29-26)19-5-3-2-4-6-19;26-20-9-8-18(15-21(20)32)25(34)31(16-23(33)30-13-4-7-19(27)11-14-30)22-10-12-28-24(29-22)17-5-2-1-3-6-17/h1-3,6,8-10,13,15-16,18,24H,4-5,7,11-12,14,17,19-21,36H2;2-3,5,7-8,10,12-13,15-16,21,37H,4,6,9,11,14,17-18,33H2,1H3;1-4,6,8-10,12-14,21,32H,5,7,11,15-18,31H2;2-9,12,15,20,32H,10-11,13-14,16-17,27H2,1H3;1-3,5-6,8-10,12,15,19,32H,4,7,11,13-14,16,27H2
InChIKeySFYREJGJPOQNFK-UHFFFAOYSA-N
MW2609.30 g/mol
LogP19.73
Rot. Bonds39

About N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide

N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide (PubChem CID 160824329) has the molecular formula C138H149ClF10N24O15 and a molecular weight of 2609.30 g/mol. Its IUPAC name is N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide.

Molecular Properties

Compound NameN-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide
PubChem CID160824329
Molecular FormulaC138H149ClF10N24O15
Molecular Weight2609.30 g/mol
Exact Mass2607.12
IUPAC NameN-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide
SMILESCOc1cc(CC(=O)N(CC(=O)N2CCC(N)CC2)c2nccc(-c3ccccc3)n2)ccc1O.Cc1ccccc1-c1cnccc1N(CC(=O)N1CCCC(N)C1)C(=O)CCc1ccc(O)c(C(F)(F)F)c1.NC1CCCCN(C(=O)CN(C(=O)CCCc2cccc(C(F)(F)F)c2F)c2ccc(OCc3ccccc3)cn2)C1.NC1CCCN(C(=O)CN(C(=O)c2ccc(Cl)c(O)c2)c2ccnc(-c3ccccc3)n2)CC1.NC1CN(C(=O)CN(C(=O)CCCc2cccc(NCC(F)(F)F)c2)c2ccc(-c3ccccc3)nn2)C1
InChIInChI=1S/C31H34F4N4O3.C29H31F3N4O3.C27H29F3N6O2.C26H29N5O4.C25H26ClN5O3/c32-30-23(10-6-13-26(30)31(33,34)35)11-7-14-28(40)39(20-29(41)38-17-5-4-12-24(36)19-38)27-16-15-25(18-37-27)42-21-22-8-2-1-3-9-22;1-19-5-2-3-7-22(19)23-16-34-13-12-25(23)36(18-28(39)35-14-4-6-21(33)17-35)27(38)11-9-20-8-10-26(37)24(15-20)29(30,31)32;28-27(29,30)18-32-22-10-4-6-19(14-22)7-5-11-25(37)36(17-26(38)35-15-21(31)16-35)24-13-12-23(33-34-24)20-8-2-1-3-9-20;1-35-23-15-18(7-8-22(23)32)16-24(33)31(17-25(34)30-13-10-20(27)11-14-30)26-28-12-9-21(29-26)19-5-3-2-4-6-19;26-20-9-8-18(15-21(20)32)25(34)31(16-23(33)30-13-4-7-19(27)11-14-30)22-10-12-28-24(29-22)17-5-2-1-3-6-17/h1-3,6,8-10,13,15-16,18,24H,4-5,7,11-12,14,17,19-21,36H2;2-3,5,7-8,10,12-13,15-16,21,37H,4,6,9,11,14,17-18,33H2,1H3;1-4,6,8-10,12-14,21,32H,5,7,11,15-18,31H2;2-9,12,15,20,32H,10-11,13-14,16-17,27H2,1H3;1-3,5-6,8-10,12,15,19,32H,4,7,11,13-14,16,27H2
InChIKeySFYREJGJPOQNFK-UHFFFAOYSA-N
XLogP19.73
TPSA527.50 Ų
H-Bond Donors9
H-Bond Acceptors29
Rotatable Bonds39
Heavy Atoms188
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002609.30
LogP ≤ 519.73
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1029

Analyze N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3,5-diaminopiperidin-1-yl)-2-oxoethyl]-N-[6-(2-fluorophenyl)-3-pyridinyl]-4-(3-methyl-2-oxobutyl)benzamide
CID 158506937
N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;(Z)-N-[2-(4-aminopiperazin-1-yl)-2-oxoethyl]-3-(2,3-dimethylphenyl)-N-(5-phenylpyrazin-2-yl)prop-2-enamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide
CID 158520706
N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;2-[[2-(3-aminoazepan-1-yl)-2-oxoethyl]-(5-phenylmethoxy-2-pyridinyl)amino]-N-(2-phenylethyl)acetamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperazin-1-yl)-2-oxoethyl]-3-(2,3-dimethylphenyl)-N-(5-phenylpyrazin-2-yl)propanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide
CID 160654182

Frequently Asked Questions

What is the IUPAC name of N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide?
The IUPAC name of N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide (CID 160824329) is N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide.
What is the SMILES notation for N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide?
The canonical SMILES for N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide is COc1cc(CC(=O)N(CC(=O)N2CCC(N)CC2)c2nccc(-c3ccccc3)n2)ccc1O.Cc1ccccc1-c1cnccc1N(CC(=O)N1CCCC(N)C1)C(=O)CCc1ccc(O)c(C(F)(F)F)c1.NC1CCCCN(C(=O)CN(C(=O)CCCc2cccc(C(F)(F)F)c2F)c2ccc(OCc3ccccc3)cn2)C1.NC1CCCN(C(=O)CN(C(=O)c2ccc(Cl)c(O)c2)c2ccnc(-c3ccccc3)n2)CC1.NC1CN(C(=O)CN(C(=O)CCCc2cccc(NCC(F)(F)F)c2)c2ccc(-c3ccccc3)nn2)C1.
What is the InChIKey of N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide?
The InChIKey is SFYREJGJPOQNFK-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H34F4N4O3.C29H31F3N4O3.C27H29F3N6O2.C26H29N5O4.C25H26ClN5O3/c32-30-23(10-6-13-26(30)31(33,34)35)11-7-14-28(40)39(20-29(41)38-17-5-4-12-24(36)19-38)27-16-15-25(18-37-27)42-21-22-8-2-1-3-9-22;1-19-5-2-3-7-22(19)23-16-34-13-12-25(23)36(18-28(39)35-14-4-6-21(33)17-35)27(38)11-9-20-8-10-26(37)24(15-20)29(30,31)32;28-27(29,30)18-32-22-10-4-6-19(14-22)7-5-11-25(37)36(17-26(38)35-15-21(31)16-35)24-13-12-23(33-34-24)20-8-2-1-3-9-20;1-35-23-15-18(7-8-22(23)32)16-24(33)31(17-25(34)30-13-10-20(27)11-14-30)26-28-12-9-21(29-26)19-5-3-2-4-6-19;26-20-9-8-18(15-21(20)32)25(34)31(16-23(33)30-13-4-7-19(27)11-14-30)22-10-12-28-24(29-22)17-5-2-1-3-6-17/h1-3,6,8-10,13,15-16,18,24H,4-5,7,11-12,14,17,19-21,36H2;2-3,5,7-8,10,12-13,15-16,21,37H,4,6,9,11,14,17-18,33H2,1H3;1-4,6,8-10,12-14,21,32H,5,7,11,15-18,31H2;2-9,12,15,20,32H,10-11,13-14,16-17,27H2,1H3;1-3,5-6,8-10,12,15,19,32H,4,7,11,13-14,16,27H2.
What are the key properties of N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide?
N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide has a molecular weight of 2609.30 g/mol, XLogP of 19.73, 39 rotatable bonds, 9 hydrogen bond donors, and 29 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(4-aminoazepan-1-yl)-2-oxoethyl]-4-chloro-3-hydroxy-N-(2-phenylpyrimidin-4-yl)benzamide;N-[2-(3-aminoazepan-1-yl)-2-oxoethyl]-4-[2-fluoro-3-(trifluoromethyl)phenyl]-N-(5-phenylmethoxy-2-pyridinyl)butanamide;N-[2-(3-aminoazetidin-1-yl)-2-oxoethyl]-N-(6-phenylpyridazin-3-yl)-4-[3-(2,2,2-trifluoroethylamino)phenyl]butanamide;N-[2-(4-aminopiperidin-1-yl)-2-oxoethyl]-2-(4-hydroxy-3-methoxyphenyl)-N-(4-phenylpyrimidin-2-yl)acetamide;N-[2-(3-aminopiperidin-1-yl)-2-oxoethyl]-3-[4-hydroxy-3-(trifluoromethyl)phenyl]-N-[3-(2-methylphenyl)-4-pyridinyl]propanamide is sourced from PubChem (CID 160824329), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).